Period of time： 2013年5期
Publisher： Informa Healthcare
Founded in： 2008
Total resources： 4
ISSN： 1751-2433
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Review of Clinical Pharmacology,volume 5,issue 5
Menu
Open innovation: the new face of pharmaceutical research and development
By Getz Kenneth A,Kaitin Kenneth I in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.
Access to resources
Recommend
Pharmacovigilance in Europe: direction of travel in a changing environment
By Hidalgo-Simon Ana,Arlett Peter in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.Viral vectors: promising new therapeutics in the battle against glioblastoma
By Salehi Afshin,Chen Clark C,Carter Bob S in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.Medicines for pediatric oncology: can we overcome the failure to deliver?
By Saint-Raymond Agnes,Herold Ralf in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.Pegloticase and the patient with treatment-failure gout
By Dave Amish J,Kelly Victoria M,Krishnan Eswar in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.Early response of ceftaroline fosamic in the treatment of soft-tissue infections
By Giuliano Christopher,Kale-Pradhan Pramodini B,Johnson Leonard B in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.Clinical trials involving the oncolytic virus, reovirus: ready for prime time?
By Black Allison J,Morris Don G in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.By Liu Rong,Dong Hui-Fen,Jiang Ming-Sen in (2012)
Expert Review of Clinical Pharmacology,volume 5,issue 5 , Vol. 5, Iss. 5, 2012-09 , pp.
Previous
Next